Literature DB >> 15265711

BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.

Megan Fabbro1, Stefan Schuechner, Wendy W Y Au, Beric R Henderson.   

Abstract

BRCA1 is involved in maintaining genomic integrity and, as a regulator of the G2/M checkpoint, contributes to DNA repair and cell survival. The overexpression of BRCA1 elicits diverse cellular responses including apoptosis due to the stimulation of specific signaling pathways. BRCA1 is normally regulated by protein turnover, but is stabilized by BARD1 which can recruit BRCA1 to the nucleus to form a ubiquitin E3 ligase complex involved in DNA repair or cell survival. Here, we identify BARD1 as a regulator of BRCA1-dependent apoptosis. Using transfected MCF-7 breast cancer cells, we found that BRCA1-induced apoptosis was independent of p53 and was stimulated by BRCA1 nuclear export. Conversely, BARD1 reduced BRCA1-dependent apoptosis by a mechanism involving nuclear sequestration. Regulation of apoptosis by BARD1 was reduced by BRCA1 cancer mutations that disrupt Ub ligase function. Transfection of BRCA1 N-terminal peptides that disrupted the cellular BRCA1-BARD1 interaction caused a loss of nuclear BRCA1 that correlated with increased apoptosis in single cell assays, but did not alter localization or expression of endogenous BARD1. Reducing BARD1 levels by siRNA caused a small increase in apoptosis. Our findings identify a novel apoptosis inhibitory function of BARD1 and suggest that nuclear retention of BRCA1-BARD1 complexes contributes to both DNA repair and cell survival.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265711     DOI: 10.1016/j.yexcr.2004.05.004

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

Review 1.  Dynamic changes in gene expression during human early embryo development: from fundamental aspects to clinical applications.

Authors:  Said Assou; Imène Boumela; Delphine Haouzi; Tal Anahory; Hervé Dechaud; John De Vos; Samir Hamamah
Journal:  Hum Reprod Update       Date:  2010-08-17       Impact factor: 15.610

Review 2.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

3.  Identifying new human oocyte marker genes: a microarray approach.

Authors:  Stéphan Gasca; Franck Pellestor; Saïd Assou; Vanessa Loup; Tal Anahory; Hervé Dechaud; John De Vos; Samir Hamamah
Journal:  Reprod Biomed Online       Date:  2007-02       Impact factor: 3.828

4.  Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.

Authors:  Amy L Creekmore; Yvonne S Ziegler; Jamie L Bonéy; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

5.  BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.

Authors:  Przemyslaw Juszczynski; Jeffery L Kutok; Cheng Li; Joydeep Mitra; Ricardo C T Aguiar; Margaret A Shipp
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 6.  BRCA1 gene: function and deficiency.

Authors:  Miho Takaoka; Yoshio Miki
Journal:  Int J Clin Oncol       Date:  2017-09-07       Impact factor: 3.402

7.  Synthetic Lethality of PARP Inhibition and Ionizing Radiation is p53-dependent.

Authors:  Steven T Sizemore; Rahman Mohammad; Gina M Sizemore; Somaira Nowsheen; Hao Yu; Michael C Ostrowski; Arnab Chakravarti; Fen Xia
Journal:  Mol Cancer Res       Date:  2018-03-28       Impact factor: 5.852

8.  Pattern of breast cancer susceptibility gene 1 expression is a potential prognostic biomarker in resectable pancreatic ductal adenocarcinoma.

Authors:  Tong Wang; Sabrina C Wentz; Natalie L Ausborn; M Kay Washington; Nipun Merchant; Zhiguo Zhao; Yu Shyr; A Bapsi Chakravarthy; Fen Xia
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

9.  The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.

Authors:  Serena C Hedgepeth; M Iveth Garcia; Larry E Wagner; Ana M Rodriguez; Sree V Chintapalli; Russell R Snyder; Gary D V Hankins; Beric R Henderson; Kirsty M Brodie; David I Yule; Damian B van Rossum; Darren Boehning
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

10.  Targeting BRCA1 localization to augment breast tumor sensitivity to poly(ADP-Ribose) polymerase inhibition.

Authors:  Eddy S Yang; Somaira Nowsheen; Mohammad A Rahman; Rebecca S Cook; Fen Xia
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.